Sidorenkov G; Navis G (2014). “Safety of ACE inhibitor therapies in patients with chronic kidney disease”. 《Expert Opinion on Drug Safety》 13 (10): 1383–1395. doi:10.1517/14740338.2014.951328. PMID25148900.
Cohn JN; Kowey PR; Whelton PK; Prisant LM (2000). “New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice”. 《The Archives of Internal Medicine》 160 (16): 2429–36. doi:10.1001/archinte.160.16.2429. PMID10979053.
Molinaro G; Cugno M; Perez M; Lepage Y; Gervais N; Agostoni A; Adam A (2002). “Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin”. 《The Journal of Pharmacology and Experimental Therapeutics》 303 (1): 232–7. doi:10.1124/jpet.102.038067. PMID12235256.
Bullo M; Tschumi S; Bucher BS; Bianchetti MG; Simonetti GD (2012). “Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists: A Systematic Review”. 《Hypertension》 60 (2): 444–50. doi:10.1161/HYPERTENSIONAHA.112.196352. PMID22753220.
globalrph.com
Common Medication Conversions (Equivalents): Ace InhibitorsArchived 2015년 3월 17일 - 웨이백 머신. GlobalRPh.com. Accessed 2009-11-22.
Sidorenkov G; Navis G (2014). “Safety of ACE inhibitor therapies in patients with chronic kidney disease”. 《Expert Opinion on Drug Safety》 13 (10): 1383–1395. doi:10.1517/14740338.2014.951328. PMID25148900.
Thomas MC (2000). “Diuretics, ACE inhibitors and NSAIDs--the triple whammy”. 《The Medical journal of Australia》 172 (4): 184–5. PMID10772593.
Cohn JN; Kowey PR; Whelton PK; Prisant LM (2000). “New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice”. 《The Archives of Internal Medicine》 160 (16): 2429–36. doi:10.1001/archinte.160.16.2429. PMID10979053.
Molinaro G; Cugno M; Perez M; Lepage Y; Gervais N; Agostoni A; Adam A (2002). “Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin”. 《The Journal of Pharmacology and Experimental Therapeutics》 303 (1): 232–7. doi:10.1124/jpet.102.038067. PMID12235256.
Sørensen AM; Christensen S; Jonassen TE; Andersen D; Petersen JS (March 1998). “[Teratogenic effects of ACE-inhibitors and angiotensin II receptor antagonists]”. 《Ugeskrift for Laeger》 (덴마크어) 160 (10): 1460–4. PMID9520613.
Bullo M; Tschumi S; Bucher BS; Bianchetti MG; Simonetti GD (2012). “Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists: A Systematic Review”. 《Hypertension》 60 (2): 444–50. doi:10.1161/HYPERTENSIONAHA.112.196352. PMID22753220.